Xilio Therapeutics Inc. – Filings and Transcripts

NASDAQ: XLO
Share price (11/13/26): $8.07
Market cap (11/13/26): $57.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Shelf registration – amended

Shelf registration

Registration of securities for employees

Ownership Filter

Coastlands Capital LP

Adage Capital Management, L.P.

Stempoint Capital LP

News Filter

Reports Third Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness